Експериментальна та клінічна фізіологія і біохіміяAbstract. According to statistics, millions of people around the world have been infected with or are currently infected with the SARS-CoV-2 virus, which causes respiratory, cardiovascular, and urinary tract damage. It is known that vitamins D and C have immune-boosting properties that help protect the body against infection. Various studies have shown that a deficiency in these vitamins increases the risk and severity of the disease. This has drawn attention to the impact of vitamins on people infected with the SARS-CoV-2 virus. Vitamin D has been found to play a role in the production of protective peptides: β-defensins and cathelicidins, and modulates the activity of the renin-angiotensin-aldosterone system. β-defensins are responsible for perforating the virus capsid, while cathelicidins promote the dilation of blood vessel walls, which increases the influx of macrophages and their activation. Vitamin C, on the other hand, inhibits the activity of the cytokine storm that occurs as a result of hyperinflammation in affected areas of the body and also reduces the level of IL-6 and inhibits in vivo release of IL-6 in endothelium induced by endothelin-1 (ET-1). In this article, we review current research on the role of vitamins D and C in supporting immunity at various levels, particularly in the context of respiratory infections, with a focus on COVID-19. These levels include recovery and antibody production against the pathogen, infection prevention, easing of disease progression, supportive therapy, and the consequences of the disease. Although studies on the impact of calciferol and ascorbic acid on coronavirus progression are still ongoing, the results obtained indicate the potential usefulness of their use in the treatment of COVID-19.
Article received: 25.04.2023
Ключові слова: COVID-19, vitamin D, vitamin С, β-defensin, cathelicidins, cytokine storm, oxidative stress
Повний текст: PDF (Ukr)